TY - JOUR
T1 - NAD(P)HX dehydratase (NAXD) deficiency due to a novel biallelic missense variant and review of literature
AU - Majethia, Purvi
AU - Mishra, Shivani
AU - Rao, Lakshmi Priya
AU - Rao, Raghavendra
AU - Shukla, Anju
N1 - Funding Information:
The National Institutes of Health , United States of America funded the project titled ‘Genetic Diagnosis of Neurodevelopmental Disorders in India’ (Grant ID: 1R01HD093570-01A1).
Publisher Copyright:
© 2021
PY - 2021/9
Y1 - 2021/9
N2 - Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 (PEBEL2; MIM# 618321), caused by biallelic pathogenic variants in the NAD(P)HX dehydratase (NAXD) is a rare metabolite repair disorder. It is characterized by progressive neurological deterioration usually associated with a febrile illness. The other common findings include skin lesions, elevated serum or cerebrospinal fluid lactate levels, and brain neuroimaging abnormalities. Currently, variants in NAXD have been reported in eight unrelated individuals including six truncating and six missense variants. We report on an additional individual with characteristic findings of PEBEL2, and an additional finding of sparse scalp hair. A novel missense variant c.301G > A, p.(Ala101Thr) in a homozygous state was identified through exome sequencing. This study adds to the phenotypic and mutational spectrum of PEBEL2. We review the existing phenotypic and genotypic information for the individuals with this neurometabolic condition.
AB - Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 (PEBEL2; MIM# 618321), caused by biallelic pathogenic variants in the NAD(P)HX dehydratase (NAXD) is a rare metabolite repair disorder. It is characterized by progressive neurological deterioration usually associated with a febrile illness. The other common findings include skin lesions, elevated serum or cerebrospinal fluid lactate levels, and brain neuroimaging abnormalities. Currently, variants in NAXD have been reported in eight unrelated individuals including six truncating and six missense variants. We report on an additional individual with characteristic findings of PEBEL2, and an additional finding of sparse scalp hair. A novel missense variant c.301G > A, p.(Ala101Thr) in a homozygous state was identified through exome sequencing. This study adds to the phenotypic and mutational spectrum of PEBEL2. We review the existing phenotypic and genotypic information for the individuals with this neurometabolic condition.
UR - http://www.scopus.com/inward/record.url?scp=85108408448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108408448&partnerID=8YFLogxK
U2 - 10.1016/j.ejmg.2021.104266
DO - 10.1016/j.ejmg.2021.104266
M3 - Article
AN - SCOPUS:85108408448
SN - 1769-7212
VL - 64
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 9
M1 - 104266
ER -